Vitaly Napadow | |
---|---|
Born | 1971 (age 52–53) |
Occupation(s) | Neuroscientist, acupuncturist |
Vitaly Napadow is an American neuroscientist and acupuncturist. He is a full professor of Physical Medicine & Rehabilitation and Radiology at Harvard Medical School. He is also the Director of the Scott Schoen and Nancy Adams Discovery Center for Recovery from Chronic Pain at Spaulding Rehabilitation Hospital and Director of the Center for Integrative Pain NeuroImaging at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital. He is a former president of the Society for Acupuncture Research.[1] He has been a pain neuroimaging researcher for more than 20 years. Somatosensory, cognitive, and affective factors all influence the malleable experience of chronic pain, and Dr. Napadow’s Lab has applied human functional and structural neuroimaging to localize and suggest mechanisms by which different brain circuitries modulate pain perception. Dr. Napadow’s neuroimaging research also aims to better understand how non-pharmacological therapies, from acupuncture and transcutaneous neuromodulation to cognitive behavioral therapy and mindfulness meditation training, ameliorate aversive perceptual states such as pain. In fact, his early career was known for researching acupuncture and its effects on the brain.[2][3] He has also researched the brain circuitry underlying nausea[4] and itch.[5] He is also known for developing a novel approach in applying measures of resting state brain connectivity as potential biomarkers for spontaneous clinical pain in chronic pain disorders such as fibromyalgia.[6]
In 2009, he invented an innovative approach to transcutaneous auricular vagus nerve stimulation (taVNS), wherein stimulation is gated to a specific phase of the respiratory cycle.[7] This form of taVNS, called Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS), has been evaluated for pain, depression, hypertension, functional dyspepsia, and other medical disorders.
In 2016, he applied hyperscanning fMRI to evaluate the patient-clinician relationship and how therapeutic alliance and the "art of medicine" impacts clinical outcomes for many different therapies. The first publication came out in 2020, linking brain-to-brain concordance in the temporoparietal junction to anesthesia in chronic pain patients.[8]